Deferoxamine Injection and Mesalamine Controlled-Release Capsules
Determining the interaction of Deferoxamine Injection and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferoxamine
Brand name: Desferal
Synonyms: Deferoxamine
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferoxamine Injection-Mesalamine Delayed Release Tablets
- Deferoxamine Injection-Mesalamine Long-Acting Capsules (Apriso)
- Deferoxamine Injection-Mesalamine Long-Acting Capsules (Delzicol)
- Deferoxamine Injection-Mesalamine Long-Acting Capsules (Pentasa)
- Deferoxamine Injection-Mesalamine rectal
- Deferoxamine Injection-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Deferoxamine Mesylate
- Mesalamine Controlled-Release Capsules-Defibrotide
- Mesalamine Controlled-Release Capsules-Defibrotide Intravenous
- Mesalamine Controlled-Release Capsules-Defibrotide Sodium
- Mesalamine Controlled-Release Capsules-Definity
- Mesalamine Controlled-Release Capsules-Defitelio